Why extracted DNA can still inhibit PCR

DNA extraction separates nucleic acids from a complex starting material, but an extract may retain substances that affect polymerase activity, primer annealing or fluorescence measurement. Depending on the specimen, potential inhibitors include haemoglobin or heme from blood, humic substances from soil, polysaccharides and phenolic compounds from plants, and residual processing reagents. Their effects depend on concentration, assay chemistry and target abundance.

UV-Vis ratios alone cannot establish absence of inhibition. An extract with apparently normal A260/A280 can still interfere with amplification. Conversely, a poor absorbance ratio does not prove that a particular qPCR reaction will fail. Start with the actual assay and its controls. See our DNA quality-control guide for the differences between purity indicators, quantity and functional suitability.

Read the controls before changing the extraction

A no-template control can identify reaction contamination, while a suitable positive amplification control helps identify failures of reagents, cycling or assay setup. An extraction blank can reveal contamination introduced during sample processing. An internal amplification control, when appropriately designed and incorporated, can provide evidence of sample-specific suppression. Controls answer different questions and should not be treated as substitutes for one another.

For qPCR, interpret Cq values and curve shape in the context of replicate variability and established assay performance. A delayed Cq can reflect inhibition, but also lower starting target copies, poor reverse transcription in RT-qPCR, DNA fragmentation or sampling noise near the detection limit. MIQE guidance emphasises describing control strategy, sample preparation and inhibition assessment rather than inferring quality from one metric.

A dilution check: useful, but easy to misread

Compare a neat extract with a defined dilution, alongside the assay’s normal controls. Dilution reduces the concentration of inhibitory substances, but it also reduces target copy number. In a well-behaved, efficient qPCR with sufficient template, a tenfold dilution would ordinarily shift Cq later by approximately 3.3 cycles. This is an idealised expectation, not a universal pass/fail rule; assay efficiency and low-copy stochastic effects affect interpretation.

If a diluted extract amplifies more readily than expected, inhibition is plausible. If both extracts weaken predictably, low template abundance or other failure modes remain possible. A sample that appears negative when undiluted but positive after dilution is an important clue, but repeatability and appropriate controls are essential. When required, use a dedicated inhibition control with an accepted assay-specific response range.

Troubleshooting decision table

When to clean up, re-extract or change the input

Once inhibition is supported by controls, choose the least disruptive corrective action permitted by the downstream assay. This may include an appropriately evaluated dilution, further purification, adjusting the specimen input, or selecting an extraction workflow designed for the actual matrix. A secondary cleanup can remove inhibitors, but may also reduce DNA recovery and compromise low-copy applications; measure the impact on total recoverable target.

For challenging agricultural and environmental material, examine the extraction workflow from sample homogenisation onwards, not only the final eluate. Gene Vantage offers IsoBind Compost DNA Kit for its specified research sample types and a wider genomic DNA extraction range. Select the product on the basis of the current product information and sample matrix; suitability is not established merely by the presence of inhibitors.

A practical investigation sequence

1. Record the specimen matrix, extraction batch, input amount and measured DNA quantity.
2. Review amplification curves, positive controls, no-template controls and extraction blanks.
3. Use an appropriate internal control to investigate sample-associated suppression.
4. Compare neat and diluted extracts only where the assay permits, accounting for target dilution.
5. Assess whether fragmentation, low target abundance or collection history provides a better explanation.
6. Document the action chosen, the change in QC measures and the downstream result.

The same protocol need not work equally well for blood, soil, plant tissue and low-biomass specimens. Record an assay-relevant endpoint, not simply a higher UV concentration.

Frequently asked questions

Can DNA have good NanoDrop ratios and still inhibit PCR?

Yes. Ratios screen selected types of interference but are not functional amplification tests.

Does sample dilution always fix inhibition?

No. Dilution lowers both inhibitors and target molecules. It can cause genuine low-copy positives to disappear.

Is a late Cq proof of inhibition?

No. Consider template abundance, efficiency, controls and replicate behaviour.

Should I increase DNA input when PCR is weak?

Not automatically. More input can increase inhibitor load and worsen amplification.

How is this guide different from general PCR troubleshooting?

It focuses on extraction-linked suppression and discriminating it from template scarcity or assay failure. For reaction optimisation, see Fine-Tuning Your PCR Reactions.

References and further reading

1. MIQE 2.0 quantitative PCR guidelines
2. Technical background: strategies for overcoming qPCR inhibitors
3. Technical background: types of PCR inhibition

Source material informs general scientific principles. Follow the latest product instructions and laboratory requirements for the specific specimen and assay.